Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002072 · ClinicalTrials.gov registry record · NA
A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy
A NA study, sponsored by Ortho Pharmaceuticals.
- Completed
- Registry status
- NA
- Development phase
NCT00002072 is a NA study that has completed, run by Ortho Pharmaceuticals.
The verdict
NCT00002072, a NA study, has completed, sponsored by Ortho Pharmaceuticals.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To determine the safety and efficacy of erythropoietin (r-HUEPO) administered to AIDS patients with anemia secondary to their disease and/or concomitant zidovudine (AZT) therapy.
Interventions
- DRUG Epoetin alfa
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002072
The ClinicalTrials.gov registry entry for NCT00002072 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Ortho Pharmaceuticals, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Epoetin alfa is the first listed.
NCT00002072 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002072 about?
NCT00002072 is a clinical study titled "A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy". To determine the safety and efficacy of erythropoietin (r-HUEPO) administered to AIDS patients with anemia secondary to their disease and/or concomitant zidovudine (AZT) therapy.
What is the current status of trial NCT00002072?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002072?
The interventions under investigation include: Epoetin alfa (DRUG).
Who is sponsoring clinical trial NCT00002072?
This trial is sponsored by Ortho Pharmaceuticals, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.